Lars Hartwin Lindner
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
-
- Sarcoma Diagnosis and Treatment
- Renal cell carcinoma treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 77
- Biomaterials 17
- Nanoparticle-Based Drug Delivery 17
- Co-authors
- Rolf Dieter Issels (46 shared papers)Martin Hossann (26 shared papers)Gerben A. Koning (5 shared papers)Timo L.M. ten Hagen (5 shared papers)Michael Peller (13 shared papers)Alexander M.M. Eggermont (4 shared papers)Gerhard Winter (5 shared papers)Hans Roland Dürr (30 shared papers)
- Journals
- Cancers (14 papers)International Journal of Hyperthermia (13 papers)Annals of Oncology (11 papers)Journal of Controlled Release (10 papers)European Journal of Cancer (9 papers)
- Partner nations
- GermanyNetherlandsFrance
In The Last Decade
Lars Hartwin Lindner
163 papers receiving 6.0k citations
Lars Hartwin Lindner's Hit Papers
Peers
Comparison fields: 5 of 82
- Biomaterials 1.2k
- Pulmonary and Respiratory Medicine 1.3k
- Gastroenterology 251
- Biomedical Engineering 1.0k
- Rheumatology 366
Countries citing papers authored by Lars Hartwin Lindner
This map shows the geographic impact of Lars Hartwin Lindner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Hartwin Lindner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Hartwin Lindner more than expected).
Fields of papers citing papers by Lars Hartwin Lindner
This network shows the impact of papers produced by Lars Hartwin Lindner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Hartwin Lindner. The network helps show where Lars Hartwin Lindner may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Hartwin Lindner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 182 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study Hit paper breakdown → | 2010 | 556 |
| 2 | 2012 | 409 | |
| 3 | 2014 | 306 | |
| 4 | An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG) Hit paper breakdown → | 2017 | 277 |
| 5 | 2018 | 260 | |
| 6 | 2004 | 229 | |
| 7 | 2010 | 222 | |
| 8 | 2010 | 189 | |
| 9 | 2017 | 155 | |
| 10 | 2018 | 153 | |
| 11 | 2020 | 126 | |
| 12 | 2007 | 120 | |
| 13 | 2012 | 114 | |
| 14 | 2017 | 102 | |
| 15 | 2016 | 98 | |
| 16 | 2017 | 98 | |
| 17 | 2010 | 97 | |
| 18 | 2002 | 83 | |
| 19 | 2014 | 81 | |
| 20 | 2017 | 80 |
About Lars Hartwin Lindner
Lars Hartwin Lindner is a scholar working on Pulmonary and Respiratory Medicine, Biomaterials, Biomedical Engineering, Oncology and Gastroenterology, having authored 182 papers that have together received 6.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (77 papers), Ultrasound and Hyperthermia Applications (22 papers), Nanoparticle-Based Drug Delivery (17 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA Interference and Gene Delivery (3 papers), Vascular Tumors and Angiosarcomas (3 papers) and Bone Tumor Diagnosis and Treatments (2 papers). The work is most often cited by research in Biomaterials (1.2k citations), Pulmonary and Respiratory Medicine (1.3k citations), Gastroenterology (251 citations), Biomedical Engineering (1.0k citations) and Rheumatology (366 citations). Lars Hartwin Lindner has collaborated with scholars based in Germany, Netherlands and France. Frequent co-authors include Rolf Dieter Issels, Martin Hossann, Gerben A. Koning, Timo L.M. ten Hagen, Michael Peller, Alexander M.M. Eggermont, Gerhard Winter, Hans Roland Dürr, Thomas Knösel and Andrea Baur‐Melnyk. Their work appears in journals such as Cancers, International Journal of Hyperthermia, Annals of Oncology, Journal of Controlled Release and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.